BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16698424)

  • 1. Transcriptional control of activation-induced cytidine deaminase and error-prone DNA polymerases is functionally mature in the B cells of infants at birth.
    Bowen AL; Tian C; LaFleur BJ; Crowe JE
    Hum Immunol; 2006; 67(1-2):43-6. PubMed ID: 16698424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations.
    Epeldegui M; Hung YP; McQuay A; Ambinder RF; Martínez-Maza O
    Mol Immunol; 2007 Feb; 44(5):934-42. PubMed ID: 16730063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
    Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
    Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflections on the state of play in somatic hypermutation.
    Steele EJ
    Mol Immunol; 2008 May; 45(10):2723-6. PubMed ID: 18359085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A backup role of DNA polymerase kappa in Ig gene hypermutation only takes place in the complete absence of DNA polymerase eta.
    Faili A; Stary A; Delbos F; Weller S; Aoufouchi S; Sarasin A; Weill JC; Reynaud CA
    J Immunol; 2009 May; 182(10):6353-9. PubMed ID: 19414788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
    Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
    Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What role for AID: mutator, or assembler of the immunoglobulin mutasome?
    Reynaud CA; Aoufouchi S; Faili A; Weill JC
    Nat Immunol; 2003 Jul; 4(7):631-8. PubMed ID: 12830138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymerase eta is involved in hypermutation occurring during immunoglobulin class switch recombination.
    Faili A; Aoufouchi S; Weller S; Vuillier F; Stary A; Sarasin A; Reynaud CA; Weill JC
    J Exp Med; 2004 Jan; 199(2):265-70. PubMed ID: 14734526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytidine deaminase AID exhibits similar functional properties in yeast and mammals.
    Rogozin IB; Pavlov YI
    Mol Immunol; 2006 Mar; 43(9):1481-4. PubMed ID: 16219354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced deaminase: light and dark sides.
    de Yébenes VG; Ramiro AR
    Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype.
    Smit LA; Bende RJ; Aten J; Guikema JE; Aarts WM; van Noesel CJ
    Cancer Res; 2003 Jul; 63(14):3894-8. PubMed ID: 12873980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA polymerase kappa deficiency does not affect somatic hypermutation in mice.
    Schenten D; Gerlach VL; Guo C; Velasco-Miguel S; Hladik CL; White CL; Friedberg EC; Rajewsky K; Esposito G
    Eur J Immunol; 2002 Nov; 32(11):3152-60. PubMed ID: 12555660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AID-initiated purposeful mutations in immunoglobulin genes.
    Goodman MF; Scharff MD; Romesberg FE
    Adv Immunol; 2007; 94():127-55. PubMed ID: 17560274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
    Popov SW; Moldenhauer G; Wotschke B; Brüderlein S; Barth TF; Dorsch K; Ritz O; Möller P; Leithäuser F
    Cancer Res; 2007 Jul; 67(14):6555-64. PubMed ID: 17638864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6.
    Rückerl F; Bachl J
    Eur J Immunol; 2005 Jan; 35(1):290-8. PubMed ID: 15593119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase.
    Willenbrock K; Jungnickel B; Hansmann ML; Küppers R
    Eur J Immunol; 2005 Oct; 35(10):3002-7. PubMed ID: 16180254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strand-biased spreading of mutations during somatic hypermutation.
    Unniraman S; Schatz DG
    Science; 2007 Aug; 317(5842):1227-30. PubMed ID: 17761884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the role of translesion synthesis DNA polymerases in Ig hypermutation.
    Diaz M; Lawrence C
    Trends Immunol; 2005 Apr; 26(4):215-20. PubMed ID: 15797512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells.
    Pasqualucci L; Kitaura Y; Gu H; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):395-400. PubMed ID: 16387847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.